Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)

56
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
102.25(c) 100.55(c) 99.88(c) 101.25(c) 101.3(c) Last
543 681 911 488 838 180 432 361 358 521 Volume
+2.39% -1.66% -0.67% +1.37% +0.05% Change
More quotes
Financials (€)
Sales 2015 13 061 M
EBIT 2015 3 100 M
Net income 2015 1 415 M
Debt 2015 10 040 M
Yield 2015 1,13%
Sales 2016 14 239 M
EBIT 2016 3 626 M
Net income 2016 1 647 M
Debt 2016 8 959 M
Yield 2016 1,25%
PER 2015 29,91
PER 2016 25,21
EV / Sales 2015 1,77x
EV / Sales 2016 1,55x
Capitalization 13 092 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.The company operates through four divisions: Merck Serono, Consumer Health, Performance Materials & Merck Millipore.The Merck Serono division is biopharmaceutical division which markets both chemical and... 
Sector
Pharmaceuticals
Calendar
08/06Earnings Release
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
02:30a THRESHOLD PHARMACEUTICALS' : Partner Merck KGaA, Darmstadt, Germany, Achieves FD..
01:01a MERCK KGAA : Serono Supports 7th International Thyroid Awareness Week to Unmask ..
05/25 MERCK KGAA : e-health, a new initiative in partnership with Kenya Ministry of He..
05/25 MERCK KGAA : e-health, a new initiative in partnership with Kenya Ministry of He..
05/23 GERMANY'S MERCK EXPECTS DRUG DIVISIO : Euro am Sonntag
05/22 MERCK KGAA : Serono Announces CHMP Positive Opinion to Extend Kuvan Use to Child..
05/22 MERCK KGAA : EMD Millipore Assigned Patent
05/22 MERCK KGAA : Leads European Research Consortium on Printed Electronics
More news
Sector news : Specialty & Advanced Pharmaceuticals
03:45a ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 62KB)
03:40a AstraZeneca hit after psoriasis drug linked to suicide fears
03:20a SHIRE : New Shire research to be presented at World Congress on ADHD highlights ..
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2014Prices move higher as positive news are released
2014A gap-filling is anticipated
More Strategies
News from SeekingAlpha
05/19 Merck KGaA (MKGAY) Management on Q1 2015 Results - Earnings Call Transcript
05/13 HyperAcute Pancreas Will Go To The Wire
05/12 Threshold Pharma's evofosfamide Fast Track'd for pancreatic cancer
04/20 Merck KGaA and Pfizer's Phase 3 avelumab study in lung cancer underway
03/19 MERCK : Why Is Sigma-Aldrich's Deal With Roche Positive For Investors?


Comments 
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions